Inventor · disambiguated record
Yimin Qian
Also filed as: QIAN YIMIN
73 granted patents·49 pending applications·324 citations·filing 2003–2025
98Inventor score
Files withARVINAS OPERATIONS INC36ACCUTAR BIOTECHNOLOGY INC21HOFFMANN LA ROCHE19ARVINAS INC15BOLIN DAVID ROBERT13
Top patents by PatentIndex Score
122 records- 0198US11104666B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Aug 31, 2021·18 cites·15 claims
- 0298US10899742B1Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Jan 26, 2021·18 cites·25 claims
- 0398US10647698B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS INC·Filed 2017·Granted May 12, 2020·31 cites·6 claims
- 0497US11597720B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Mar 7, 2023·4 cites·48 claims
- 0597US11420956B2Ureas having Androgen Receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Aug 23, 2022·6 cites·21 claims
- 0697US10800770B1Chroman derivatives having estrogen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Oct 13, 2020·9 cites·22 claims
- 0797US10730870B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS INC·Filed 2016·Granted Aug 4, 2020·25 cites·22 claims
- 0896US11312702B2Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Apr 26, 2022·4 cites·20 claims
- 0996US10772962B2Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS INC·Filed 2016·Granted Sep 15, 2020·15 cites·23 claims
- 1095US11535606B2Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Dec 27, 2022·4 cites·34 claims
- 1195US11261178B2Chroman derivatives having estrogen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Mar 1, 2022·5 cites·9 claims
- 1295US10836749B1Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Nov 17, 2020·3 cites·25 claims
- 1395US10723717B2Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptidesARVINAS INC·Filed 2017·Granted Jul 28, 2020·16 cites·44 claims
- 1495US8058299B2Diacylglycerol acyltransferase inhibitorsBOLIN DAVID ROBERT·Filed 2008·Granted Nov 15, 2011·26 cites·18 claims
- 1595US7807674B2Thyroid hormone analogsHOFFMANN LA ROCHE·Filed 2008·Granted Oct 5, 2010·35 cites·19 claims
- 1693US11220490B2Ureas having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2021·Granted Jan 11, 2022·2 cites·10 claims
- 1793US7452882B2Thyroid hormone analogsHOFFMANN LA ROCHE·Filed 2006·Granted Nov 18, 2008·24 cites·11 claims
- 1891US11384063B2Modulators of estrogen receptor proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2020·Granted Jul 12, 2022·2 cites·8 claims
- 1990US2025320195A1Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2089US11191741B2Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptideARVINAS OPERATIONS INC·Filed 2017·Granted Dec 7, 2021·3 cites·13 claims
- 2188US11352351B2Compounds and methods for the targeted degradation of androgen receptorARVINAS INC·Filed 2016·Granted Jun 7, 2022·4 cites·16 claims
- 2287US10604506B2Modulators of estrogen receptor proteolysis and associated methods of useARVINAS INC·Filed 2018·Granted Mar 31, 2020·3 cites·20 claims
- 2387US7714126B2Diacylglycerol acyltransferase inhibitorsVIA PHARMACEUTICALS INC·Filed 2006·Granted May 11, 2010·13 cites·11 claims
- 2485US11427548B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Aug 30, 2022·2 cites·15 claims
- 2585US2025228944A1Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 2684US11512083B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Nov 29, 2022·1 cites·17 claims
- 2784US2024076281A1Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
- 2882US12473223B1Intelligent wastewater purification and treatment deviceZHEJIANG INST OF HYDRAULICS & ESTUARY ZHEJIANG INST OF MARINE PLANNING AND DESIGN·Filed 2025·Granted Nov 18, 2025·1 cites·8 claims
- 2982US8115011B2Diacylglycerol acyltransferase inhibitorsBOLIN DAVID ROBERT·Filed 2008·Granted Feb 14, 2012·6 cites·23 claims
- 3082US2025223265A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 3181US10865202B2Indole derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2019·Granted Dec 15, 2020·1 cites·20 claims
- 3280US12171831B2Compounds and methods for the targeted degradation of bromodomain- containing proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Dec 24, 2024·0 cites·14 claims
- 3380US8124766B2Inhibitors of diacylglycerol acyltransferaseBOLIN DAVID ROBERT·Filed 2009·Granted Feb 28, 2012·5 cites·52 claims
- 3479US12441708B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 3579US12239711B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Mar 4, 2025·0 cites·1 claims
- 3679US12195459B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Granted Jan 14, 2025·0 cites·46 claims
- 3779US12110291B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·32 claims
- 3879US9988397B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jun 5, 2018·2 cites·6 claims
- 3979USRE46024EThyroid hormone analogsHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·2 cites·19 claims
- 4079US9321738B2N-alkyltriazole compounds as LPAR antagonistsHOFFMANN LA ROCHE·Filed 2013·Granted Apr 26, 2016·4 cites·13 claims
- 4179US2024382599A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 4278US12264157B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Apr 1, 2025·0 cites·24 claims
- 4378US12172981B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2021·Granted Dec 24, 2024·0 cites·18 claims
- 4478US8324385B2Diacylglycerol acyltransferase inhibitorsBOLIN DAVID ROBERT·Filed 2009·Granted Dec 4, 2012·4 cites·13 claims
- 4578US2025313547A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 4677US7741327B2Pyrrolidinone glucokinase activatorsHOFFMANN LA ROCHE·Filed 2009·Granted Jun 22, 2010·3 cites·31 claims
- 4777US2025360219A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 4877US2025092039A1Glutarimide-containing pan-kras-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4976US7652053B2Diaminocycloalkane MCH receptor antagonistsHOFFMANN LA ROCHE·Filed 2007·Granted Jan 26, 2010·2 cites·19 claims
- 5076US2024059686A1Compounds and methods for the targeted degradation of the androgen receptorARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 122 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yimin Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →